Rachel Massey-Chase

ORCID: 0000-0002-8072-453X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mental Health Research Topics
  • Neuroendocrine regulation and behavior
  • Stress Responses and Cortisol
  • Infant Health and Development
  • Memory and Neural Mechanisms
  • Mental Health Treatment and Access
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Tryptophan and brain disorders
  • Psychosomatic Disorders and Their Treatments
  • Receptor Mechanisms and Signaling
  • Diet and metabolism studies
  • Treatment of Major Depression
  • Neuropeptides and Animal Physiology
  • Neuroscience and Neuropharmacology Research
  • Evolutionary Psychology and Human Behavior
  • Attachment and Relationship Dynamics

University College London
2011

University of Oxford
2008-2010

Warneford Hospital
2008-2009

Acute administration of an antidepressant increases positive affective processing in healthy volunteers, effect that may be relevant to the therapeutic actions these medications. The authors investigated whether this is apparent depressed patients early treatment, prior changes mood and symptoms.In a double-blind, placebo-controlled, between-groups randomized design, examined single 4-mg dose norepinephrine reuptake inhibitor reboxetine on emotional processing. Thirty-three were recruited...

10.1176/appi.ajp.2009.09020149 article EN American Journal of Psychiatry 2009-09-16

Abstract Animal studies have shown the role of oxytocin in affiliation and attachment, recent evidence suggests that is also involved human models approach behaviour, possibly by modulating processing emotionally valenced stimuli. Although administration has been reported to decrease neural responses facial emotional information, effects on a wider range behavioural measures be sensitive antidepressant manipulation not examined. The aim this study was investigate whether intranasally...

10.1177/0269881108095705 article EN Journal of Psychopharmacology 2008-09-18

The neurokinin-1 (NK(1)) receptor antagonist, aprepitant, showed activity in several animal models of depression; however, its efficacy clinical trials was disappointing. There is little knowledge the role NK(1) receptors human emotional behaviour to help explain this discrepancy. aim current study assess effects a single oral dose aprepitant (125 mg) on processing sensitive conventional antidepressant drug administration 38 healthy volunteers, randomly allocated receive or placebo between...

10.1177/0269881109103101 article EN Journal of Psychopharmacology 2009-04-07
Coming Soon ...